TKNO

Alpha Teknova, Inc.

Nasdaq · In Vitro & In Vivo Diagnostic Substances · Inc. DE · CIK 0001850902
$4.20 -4.55% $225.2M
Insider Buying Cluster (2 insiders)High Impact Filing (7/10)8 New Institutional Positions
Vol
Market Cap$225.2M
Cap SizeMicro Cap
Inst. Holders34 funds
Inst. Value$9.5M
Inst. Activity8 buys / 2 sells
Insider Activity2B / 0S
Insider Net $$143.4K
SEC Reports4
Exchange Nasdaq·Sector In Vitro & In Vivo Diagnostic Substances·Inc. DE·CIK 0001850902·Prev Close $4.40

Recent Activity

Price Targets

Historical data — last covering-analyst action Jul 2024. No current recommendation available.
$9.00 (Jul 2024)
Current $4.20 Low $7.00 Median $8.00 High $12.00 3 analysts
$7.00 $12.00

Analyst Ratings

Historical distribution75% buy · 12 analysts · last covering-analyst action Jul 2024
4Strong Buy
5Buy
3Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Jul 10, 2024 Stephens & Co. REITERATE Overweight → Overweight
May 14, 2024 Stephens & Co. REITERATE Overweight → Overweight
Mar 12, 2024 BTIG DOWNGRADE Buy → Neutral
Jul 12, 2023 Keybanc INITIATE Sector Weight
Aug 11, 2022 Stephens & Co. MAINTAIN Overweight

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.07 $-0.07 — $-0.07 1
Next Q $-0.08 $-0.09 — $-0.08 -3% YoY 5
Current FY $-0.33 $-0.36 — $-0.29 2
Next FY $-0.24 $-0.29 — $-0.20 25% YoY 2

Top Institutional Holders

FundValueMove
ROYCE & ASSOCIATES LP$3.1MDOUBLED
BlackRock, Inc.$2.1MDOUBLED
VANGUARD CAPITAL MANAGEMENT LLC$1.3M
BANK OF AMERICA CORP$659.7K
STATE STREET CORP$448.2KDOUBLED

Recent Insider Trades

DateInsiderTypeValue
Jun 1, 2026DEMSKI MARTHAA$0.00
Jun 1, 2026ROBERTSON BRETTA$0.00
Jun 1, 2026Vos AlexanderA$0.00
Mar 6, 2026Gunstream StephenBUY$55.8K
Mar 6, 2026Lowell MatthewBUY$87.6K
34 institutional holders with $9.5M total value (3,293,565 shares) as of 2026-Q1. Top holders: ROYCE, BlackRock,, VANGUARD. Net buying activity: 8 institutions added/increased vs 2 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1ROYCE & ASSOCIATES LP1,069,162$3.1M32.5%DOUBLED +264.2%
2BlackRock, Inc.716,774$2.1M21.8%DOUBLED +128.3%
3VANGUARD CAPITAL MANAGEMENT LLC441,879$1.3M13.4%
4BANK OF AMERICA CORP /DE/228,286$659.7K6.9%
5STATE STREET CORP155,089$448.2K4.7%DOUBLED +104.1%
6GOLDMAN SACHS GROUP INC118,439$342.3K3.6%
7MORGAN STANLEY116,990$338.1K3.6%ADD +54.6%
8VANGUARD FIDUCIARY TRUST CO75,089$217.0K2.3%
9VANGUARD PORTFOLIO MANAGEMENT LLC64,511$186.4K2.0%
10CITADEL ADVISORS LLC60,381$174.5K1.8%
11MARSHALL WACE, LLP45,167$130.5K1.4%DOUBLED +286.1%
12DEUTSCHE BANK AG\35,697$103.2K1.1%DOUBLED +147.5%
13Cerity Partners LLC25,844$74.7K0.8%
14TWO SIGMA INVESTMENTS, LP19,117$55.2K0.6%ADD +66.1%
15CHARLES SCHWAB INVESTMENT MANAGEMENT INC15,747$45.5K0.5%TRIM -54.1%
16Nuveen, LLC14,158$40.9K0.4%
17RHUMBLINE ADVISERS12,274$35.5K0.4%
18Vanguard Personalized Indexing Management, LLC12,081$34.9K0.4%
19FMR LLC11,664$33.7K0.4%DOUBLED +1928.5%
20DIMENSIONAL FUND ADVISORS LP11,613$33.1K0.3%TRIM -34.5%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
ROYCE & ASSOCIATES LPDOUBLED293,5761,069,162+264.2%$3.1M2026-Q1
MORGAN STANLEYADD75,667116,990+54.6%$338.1K2026-Q1
DEUTSCHE BANK AG\DOUBLED14,42535,697+147.5%$103.2K2026-Q1
CHARLES SCHWAB INVESTMENT MANAGEMENT INCTRIM34,29815,747-54.1%$45.5K2026-Q1
FMR LLCDOUBLED57511,664+1928.5%$33.7K2026-Q1
ExodusPoint Capital Management, LPTRIM29,71210,743-63.8%$31.0K2026-Q1
CWM, LLCDOUBLED684,087+5910.3%$11.8K2026-Q1
PNC FINANCIAL SERVICES GROUP, INC.DOUBLED1061,748+1549.1%$5.1K2026-Q1
Russell Investments Group, Ltd.ADD1,2711,734+36.4%$5.0K2026-Q1
Allworth Financial LPDOUBLED196+9500.0%$278.002026-Q1
CWM, LLCADD5268+30.8%2025-Q4
MORGAN STANLEYTRIM107,52175,667-29.6%$287.5K2025-Q4
TWO SIGMA INVESTMENTS, LPADD36,99761,463+66.1%$233.6K2025-Q4
MARSHALL WACE, LLPDOUBLED12,99250,156+286.1%$190.6K2025-Q4
WELLS FARGO & COMPANY/MNADD8,26311,883+43.8%$45.2K2025-Q4
Mirae Asset Global Investments Co., Ltd.ADD2,0692,601+25.7%$9.9K2025-Q4
Russell Investments Group, Ltd.ADD9361,271+35.8%$4.8K2025-Q4
TWO SIGMA INVESTMENTS, LPTRIM70,49836,997-47.5%$229.0K2025-Q3
MARSHALL WACE, LLPNEAR_EXIT90,03212,992-85.6%$80.4K2025-Q3
WELLS FARGO & COMPANY/MNADD5,7908,263+42.7%$51.1K2025-Q3
Zurcher Kantonalbank (Zurich Cantonalbank)TRIM1,342906-32.5%$5.6K2025-Q3
FMR LLCDOUBLED171510+198.2%$3.2K2025-Q3
UBS Group AGADD1,159,6461,586,310+36.8%$7.8M2025-Q2
STATE STREET CORPDOUBLED68,645140,107+104.1%$687.9K2025-Q2
RENAISSANCE TECHNOLOGIES LLCDOUBLED47,70098,365+106.2%$483.0K2025-Q2
6 unique insiders with 8 transactions. Net insider value: $143.4K ($143.4K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 1, 2026DEMSKI MARTHA JDirectorAWARD55,000
Jun 1, 2026ROBERTSON BRETTDirectorAWARD55,000
Jun 1, 2026Vos AlexanderDirectorAWARD55,000
Mar 6, 2026Gunstream StephenPresident and CEOBUY26,000$2.15$55.8K
Mar 6, 2026Lowell MatthewChief Financial OfficerBUY40,000$2.19$87.6K
Feb 15, 2026Terrill DamonGeneral Counsel and CCOAWARD148,000
Feb 15, 2026Gunstream StephenPresident and CEOAWARD429,000
Feb 15, 2026Lowell MatthewChief Financial OfficerAWARD171,000

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Jul 2024): 75% buy across 12 analysts — 4 strong buy, 5 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Jul 2024. No current recommendation available.
$9.00 mean target (Jul 2024)
$7.00 Low $12.00 High
MetricValue
Current Price$4.20
Target Low$7.00
Target Mean$9.00
Target Median$8.00
Target High$12.00
# Analysts3
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.07 $-0.07 $-0.07 $0.0B 6.0% 1
Next Q
2026-09-30
$-0.08 $-0.09 $-0.08 -2.5% +0.0% 1↑ 1↓ $0.0B 5.9% 5
Current FY
2026-12-31
$-0.33 $-0.36 $-0.29 1↑ 0↓ $0.0B 8.2% 2
Next FY
2027-12-31
$-0.24 $-0.29 $-0.20 24.6% $0.1B 14.7% 2

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.070
7d ago$0.000-0.070
30d ago$0.000-0.070
60d ago$0.000-0.070
90d ago$0.000-0.070
4 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 4 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jul 10, 2024 Stephens & Co. REITERATE Overweight Overweight
May 14, 2024 Stephens & Co. REITERATE Overweight Overweight
Mar 12, 2024 BTIG DOWNGRADE Buy Neutral
Jul 12, 2023 Keybanc INITIATE Sector Weight
Aug 11, 2022 Stephens & Co. MAINTAIN Overweight
Mar 16, 2022 Stephens & Co. MAINTAIN Overweight
Jul 20, 2021 Stephens & Co. INITIATE Overweight
Jul 20, 2021 Cowen & Co. INITIATE Outperform
Jul 20, 2021 BTIG INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20264530075%
May 1, 20264530075%
Apr 1, 20264530075%
Mar 1, 20264530075%
Feb 1, 20264530075%
Jan 1, 20264530075%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 6, 2026
earnings
Teknova Reports First Quarter 2026 Financial Results
<p align="center"><em>First quarter 2026 total revenue was $11.1 million, up 13% over the same quarter prior year</em><br><em>Company reaffirms 2026 r
May 6, 2026
earnings_calendar
TKNO Q1 2026 Earnings Scheduled — 2026-05-06
Apr 22, 2026
earnings
Teknova to Report First Quarter 2026 Financial Results on May 6, 2026
<p>HOLLISTER, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for
Feb 26, 2026
earnings_calendar
TKNO Q4 2025 Earnings After Market Close — 2026-02-26